Statistics
Publications
7
Citations
2.1K
H-Index
7
Active since
1994
Mark Mellinger is an author at New Frontier specializing in organic synthesis, synthetic medicinal chemistry, and organic chemistry.
Publications per year
1994–2012
7
7
EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations
Michael T. McCabe, Heidi M. Ott, Gopinath Ganji et al. · Nature · 2012 · 1.8K citations
1–5 of 7